Products
B2B Zone
2nd ADC Toxicity Summit
2nd ADC Toxicity Summit
Conferences

2nd ADC Toxicity Summit

By
23 Jul 2024 - 25 Jul 2024
Free Registration

Event Details

2nd ADC Toxicity Summit

Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing companies entering into the ADC space and tackling toxicity, there is ever-increasing target and indication-competition. Considering the significant clinical setbacks witnessed in 2023, the demand to better understand the translatability of toxicities and develop more tolerable ADCs for achieving future clinical triumphs only grows stronger.

By addressing translational challenges and tackling off-target toxicities, the 2nd ADC Toxicity Summit is returning at an imperative time to allow you to prevent, predict and mitigate toxicities in order to design and develop ADCs with a wider therapeutic index and progress them to the clinic.

Join 80+ of your colleagues from Pfizer, Merck, ImmunoGen, Mersana, Daiichi Sankyo, AbbVie and more, to discuss shared challenges with ADC toxicities from in vitro all the way to the clinic. Hear from experts in toxicology and translational sciences as they disclose never-heard before toxicity data, share insights into optimal in vivo models for predictability, investigate the use of biomarkers for patient specific ADC prescription and introduce innovative strategies to transform the ADC landscape to increase therapeutic index.

Join us in uniting the leading minds in ADC toxicology, offering actionable insights to unlock the full potential of predicting and mitigating toxicities in ADC development and addressing unmet needs head-on across three days of highly focused content - Don't miss out!

URLs:
Website: https://go.evvnt.com/2381308-0?pid=10018
Tickets: https://go.evvnt.com/2381308-2?pid=10018
Brochure: https://go.evvnt.com/2381308-3?pid=10018

Prices:
FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4197.00,
Conference Only - Drug Developer: USD 2999.00,
FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5097.00,
Conference Only - Solution Provider: USD 3699.00

Speakers: Ali Warbington, Director, Toxicology, ImmunoGen, Arnima Bisht, Senior Director, Oxford BioTherapeutics, Christian Marsolais, Senior Vice-President and Chief Medical Officer, Theratechnologies Inc., Doo Young Jung, CEO, pinotbio, Grace Lytle, Executive Ocular Medical Director, ImmunoGen, Jacqueline Kinyamu-Akunda, Global Head of ADC Discovery and Development, Johnson and Johnson, Josée Hue-Perron, Associate Principal Scientist in Preclinical Safety, Debiopharm, Jutta Deckert, Vice President, Research and Development, Iksuda Therapeutics, Kristin Decker, Associate Director Pharmacology and Toxicology, Heidelberg Pharma, Laurie Tatalick, Consultant, Laurie Tatalick Consulting, Marini Thian, Senior Scientist, Takeda, Melissa Schutten, Senior Director, Pathology, Pfizer, Michael Oropallo, Principal Scientist, Merck and Co, Natalie Keirstead, Senior Vice President - Nonclinical Development, Mersana Therapeutics, Paul Jaminet, President, Angiex, Philip Huxley, Vice President, Oncology, Bicycle Therapeutics, Piper Treuting, Director - Translational Sciences and Pathology, Pfizer, Ronnie Yeager, Project Director, Emerging Therapeutic Platforms, Abbvie, Werner Rubas, Vice President - Preclinical Development, Sutro Biopharma, Zenta Tsuchihashi, Senior Director - Translational Science and Oncology, Daiichi Sankyo, Inc.

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-4:00) Eastern Time (US and Canada)
09:00 AM - 05:00 PM (Jul 23, Jul 24, Jul 25) (General)

Speakers

Ali Warbington
Ali Warbington
Director, Toxicology, ImmunoGen
Arnima Bisht
Arnima Bisht
Senior Director, Oxford BioTherapeutics
Christian Marsolais
Christian Marsolais
Senior Vice-President and Chief Medical Officer, Theratechnologies Inc.
Doo Young Jung
Doo Young Jung
CEO, pinotbio

Organizer

Hanson Wade Group

0 Followers

Hanson Wade Group specialises in bringing people together through outstanding business conferences and year round community contact. We accelerate growth across industry and across the globe. We do this by finding the right people, the right is...

Comments on 2nd ADC Toxicity Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Hilton Boston Back Bay
40, Dalton Street, Back Bay, Boston ,
Boston 02115, Massachusetts, United States
Official Link :

More Events By Organizer

13th Process Development for Highly Potent Drugs Summit (HPAPI)
13th Process Development for Highly Potent Drugs Summit (HPAPI)
25
Jun
2024
Free
Conferences
3rd Next Generation Lipid-Based Nanoparticles Delivery Summit
3rd Next Generation Lipid-Based Nanoparticles Delivery Summit
20
Aug
2024
12th Tumor Models Boston
12th Tumor Models Boston
23
Jul
2024

12th Tumor Models Boston

Suffolk County, United States
Free
Conferences
Cell and Gene Therapy Pricing and Reimbursement Summit
Cell and Gene Therapy Pricing and Reimbursement Summit
25
Jun
2024
Free
Conferences
7th Neuropsychiatric Drug Development Summit
7th Neuropsychiatric Drug Development Summit
24
Sep
2024
Free
Conferences

Similar Events

Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People